SMTL ID : 3cn2.1 (1 other biounit)

Human transthyretin (TTR) in complex with 3,5-Dibromo-4-hydroxybiphenyl

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.52 Å

Oligo State

homo-tetramer

Ligands

4 x LJ3: 3,5-dibromobiphenyl-4-ol(Non-covalent)

LJ3.1: 11 residues within 4Å: Chain A: K.15, L.17, A.108, L.110, S.117 Chain C: K.15, L.17, A.108, L.110, S.117 Ligands: LJ3.3 7 PLIP interactions: 4 interactions with chain A, 3 interactions with chain C Hydrophobic interactions: A:L.17, A:A.108, A:L.110, A:L.110, C:L.17, C:A.108, C:L.110 LJ3.2: 13 residues within 4Å: Chain B: K.15, L.17, A.108, L.110, S.117 Chain D: K.15, L.17, T.106, A.108, L.110, S.117, V.121 Ligands: LJ3.4 9 PLIP interactions: 5 interactions with chain D, 4 interactions with chain B Hydrophobic interactions: D:L.17, D:A.108, D:L.110, D:L.110, B:L.17, B:A.108, B:L.110 Hydrogen bonds: D:K.15, B:K.15 LJ3.3: 11 residues within 4Å: Chain A: K.15, L.17, A.108, L.110, S.117 Chain C: K.15, L.17, A.108, L.110, S.117 Ligands: LJ3.1 7 PLIP interactions: 3 interactions with chain A, 4 interactions with chain C Hydrophobic interactions: A:L.17, A:A.108, A:L.110, C:L.17, C:A.108, C:L.110, C:L.110 LJ3.4: 13 residues within 4Å: Chain B: K.15, L.17, T.106, A.108, L.110, S.117, V.121 Chain D: K.15, L.17, A.108, L.110, S.117 Ligands: LJ3.2 9 PLIP interactions: 4 interactions with chain D, 5 interactions with chain B Hydrophobic interactions: D:L.17, D:A.108, D:L.110, B:L.17, B:A.108, B:L.110, B:L.110 Hydrogen bonds: D:K.15, B:K.15

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Johnson, S.M. et al., Toward optimization of the linker substructure common to transthyretin amyloidogenesis inhibitors using biochemical and structural studies. J.Med.Chem. (2008)

Release Date

2008-10-28

Peptides

Transthyretin: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Transthyretin

Related Entries With Identical Sequence